Home > List All Publishers > Current Partnering

Current Partnering

CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers. CurrentPartnering publish a series of reports, providing access to critical decision making and best practice intelligence from leaders in business development and licensing.
Best practice – reports providing insight into best practice and trends in partnering
Directories – detailed analysis of partnering interests and activity of companies worldwide
Contracts – obtain an insight and understanding of the terms acceptable to a potential partner
CurrentPartnering was established in 2007 by Wildwood Ventures Ltd to offer an objective and informal business tool for business development executives, providing an opportunity for the dissemination of the latest trends in partnering activity within the biopharma sector.

List of reports from Current Partnering

Co-promotion and Co-marketing Agreements in Biopharma 1/1/2008 \| published by: Current Partnering ... and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either a right or option to co-promote/market the resultant product of the research ... \| more... Search inside this report	$2,395.00
Merger and Acquisition Agreements in Biopharma 2/1/2008 \| published by: Current Partnering ... equity transaction. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many ... \| more... Search inside this report	$2,395.00
Bigpharma Partnering Agreements 3/1/2008 \| published by: Current Partnering ... into the negotiation process in termsof what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail ... \| more... Search inside this report	$2,395.00
Distribution Agreements in Biopharma 4/1/2008 \| published by: Current Partnering ... and why companies enter distribution deals. The majority of deals are multicomponent whereby the licensor offers a right to distribute the resultant product of the research collaboration. There are also numerous pure distribution deals whereby ... \| more... Search inside this report	$2,395.00
Manufacturing and Supply Agreements in Biopharma 4/1/2008 \| published by: Current Partnering ... analysis of how and why companies enter manufacturing and supply deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect ... \| more... Search inside this report	$2,395.00
Clinical Stage Partnering Agreements in Biopharma 6/1/2008 \| published by: Current Partnering ... of how and why companies enter clinical stage partnering deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to ... \| more... Search inside this report	$2,595.00
Partnering with Bigpharma: The Definitive Guide to Partnering Interests, Contacts & Agreements 7/1/2008 \| published by: Current Partnering ... that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.Using this report, ... \| more... Search inside this report	$2,995.00
Product & Asset Purchase Agreements in Pharma, Biotech and Diagnostics 11/1/2008 \| published by: Current Partnering ... where partners have entered an agreement to dispose of or acquire said assets. The report focuses on four primary types of asset available for purchase: Business assets - the most common asset exchanging hands. Business ... \| more... Search inside this report	$2,395.00
Royalty Financing Agreements in Pharma, Biotech and Diagnostics 1/1/2009 \| published by: Current Partnering ... and analysis of how and why companies enter royalty financing partnering deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can ... \| more... Search inside this report	$995.00
Option & Evaluation Agreements in Pharma and Biotech 3/1/2009 \| published by: Current Partnering ... of the latest option and evaluation agreements announced in the pharmaceutical and biotechnology sectors. Detailed and comprehensive, the report provides details of option and evaluation agreements from 2003 to end 2008. The report provides a ... \| more... Search inside this report	$1,995.00
Practical Guide to Finding Partners in Biopharma 4/1/2009 \| published by: Current Partnering ... managing of discussions through to deal negotiation. In addition, the report provides a detailed overview of the activities a business development executive and a company should be undertaking to build and maintain an extensive contact ... \| more... Search inside this report	$995.00
Oncology Partnering Agreements in Pharma, Biotech and Diagnostics 6/1/2009 \| published by: Current Partnering ... and analysis of how and why companies enter oncology partnering deals. The majority of deals are discovery, preclinical or clinical whereby the licensee obtains a right or an option right to license the licensors oncology ... \| more... Search inside this report	$2,395.00
Partnering Agreements in Diagnostics 9/1/2009 \| published by: Current Partnering ... and why companies enter diagnostic partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors diagnostic technology or product candidates. These deals ... \| more... Search inside this report	$2,395.00
Partnering Agreements with Abbott 1/1/2010 \| published by: Current Partnering ... Abbott and its partnering interests and activities over the past five years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next ... \| more... Search inside this report	$495.00
Partnering Agreements with Actavis 1/1/2010 \| published by: Current Partnering ... Actavis and its partnering interests and activities over the past five years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next ... \| more... Search inside this report	$495.00
Partnering Agreements with Alcon 1/1/2010 \| published by: Current Partnering ... Alcon and its partnering interests and activities over the past five years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next ... \| more... Search inside this report	$495.00
Partnering Agreements with Allergan 1/1/2010 \| published by: Current Partnering ... Allergan and its partnering interests and activities over the past five years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next ... \| more... Search inside this report	$495.00
Partnering Agreements with Amgen 1/1/2010 \| published by: Current Partnering ... Amgen and its partnering interests and activities over the past five years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next ... \| more... Search inside this report	$495.00
Partnering Agreements with AstraZeneca 1/1/2010 \| published by: Current Partnering ... AstraZeneca and its partnering interests and activities over the past five years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next ... \| more... Search inside this report	$495.00
Partnering Agreements with Baxter 1/1/2010 \| published by: Current Partnering ... Baxter and its partnering interests and activities over the past five years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next ... \| more... Search inside this report	$495.00
Partnering Agreements with Bristol-Myers Squibb 1/1/2010 \| published by: Current Partnering ... understand Bristol-Myers Squibb and its partnering interests and activities over the past five years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of ... \| more... Search inside this report	$495.00
Partnering Agreements with Chugai 1/1/2010 \| published by: Current Partnering ... Chugai and its partnering interests and activities over the past five years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next ... \| more... Search inside this report	$495.00
Partnering Agreements with Daiichi Sankyo 1/1/2010 \| published by: Current Partnering ... understand Daiichi Sankyo and its partnering interests and activities over the past five years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of ... \| more...	$495.00
Partnering Agreements with Eli Lilly 1/1/2010 \| published by: Current Partnering ... understand Eli Lilly and its partnering interests and activities over the past five years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of ... \| more... Search inside this report	$495.00
Partnering Agreements with Genzyme 1/1/2010 \| published by: Current Partnering ... Genzyme and its partnering interests and activities over the past five years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next ... \| more... Search inside this report	$495.00

< prev 1 2 3 4 next >